IRF5 and systemic lupus erythematosus: Li et al. compared healthy individuals with the homozygous IRF5 SLE-risk haplotype and healthy individuals without this haplotype, and found that the former group had a higher rate of antinuclear and anti-SS-A antibody positivity, a higher proportion of plasma cells, and increased NETosis in neutrophils [47].